The New Skin Stretching Device for Treatment of Limb Tension Wounds (SSDRCT)

The New Skin Stretching Device for Treatment of Limb Tension Wounds: A Multicenter Randomized Controlled Clinical Study

A randomized controlled trial is performed to evaluate the effectiveness and safety of the Skin Stretching Device (SSD) on limb tension incision closure by comparing whether the differences in wounds area, wounds closure time and scar assessment between the SSD and the skin grafting are statistically significant.

Study Overview

Detailed Description

Design:

This study is a multicenter and randomized control study with the participation of 15 major national or regional central hospitals. And the whole sample size is set to be 100 patients.

Patients who have been screened by inclusion and exclusion criteria will be randomly (non-transparent envelope) assigned to Skin Stretching Group (SS Group) or Skin Grafting Group (SG Group). Patients of both group will undergo surgical debridement for the same principle, while the Skin Stretching Device is used for the patients of SS Group for incision closure and the Skin Grafting is used for the patients of SG group for incision closure.

Outcome evaluation:

Wound and scar evaluation during surgery, three and six months after surgery will include the following parameters:

  • surface area;
  • Vancouver scar scale (VSS)
  • vascularization and pigmentation;
  • dermal architecture. After 3 and 6 months patients will undergo a biopsy of the scar under local anesthesia. The experimental group, treated with the SSD will undergo one extra biopsy of the formerly stretched skin.

Safety evaluation:

During the trial, adverse events are observed and evaluated. Adverse reactions to clinical manifestations are followed and recorded till the symptoms disappear. The subject with serious adverse events shall withdraw from the study and be treated accordingly.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Liaoning
      • Dalian, Liaoning, China, 116011
        • The First Affiliated Hospital of Dalian Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  1. Age≥18 years old
  2. Tension incision that cannot be directly closed due to limb trauma or surgical debridement
  3. Incision that cannot be directly closed after the incision decompression for fascia compartment syndrome and ischemia and reperfusion injury
  4. Both sides of the incision skin suitable for skin stretching

Exclusion criteria:

  1. Age <18 years old
  2. Skin disease
  3. Keloid history
  4. Local or systemic use of hormones
  5. Systemic diseases: for example, diabetes, immunodeficiency disease, vascular disease and etc.
  6. Other poor general state to result in inability for trial;
  7. Mental illness.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Skin Stretching Device (SSD)
the wound is primarily closed by aid of the SSD after necessary surgical debridement.
By making use of skin viscoelasticity, the special metal crochet of SSD would be embedded in both sides skin of the wound. Multiple cycles of stretching and relaxing wound lead to extended skin, changing the high tension incision into a low tension incision and facilitating the direct suture.
ACTIVE_COMPARATOR: Skin Grafting (SG)
the wound is primarily closed by the technique of skin grafting after necessary surgical debridement.
the standard technique of skin grafting after wound preparation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the change of surface area of the scar
Time Frame: change from surgery at 6 months
it is performed by tracing the area of the scar directly onto non-stretchable transparent sterile sheets. then digitized and analyzed by software.
change from surgery at 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Operation time
Time Frame: during surgery
refers to the time required for the application of skin stretching device or skin grafting
during surgery
Wound site and wound healing time
Time Frame: from surgery to 6 months
record the site of the operation, and the time from the beginning of surgery to the complete healing of the wound.
from surgery to 6 months
Vancouver scar scale (VSS)
Time Frame: 3 and 6 months after surgery
evaluate the scar scale by VSS
3 and 6 months after surgery
scar vascularization index
Time Frame: 3 and 6 months after surgery
use photometric analyzer to measure its erythema index, assessing its angiogenesis and vascularization
3 and 6 months after surgery
scar pigmentation index
Time Frame: 3 and 6 months after surgery
use photometric analyzer to measure its melanin index, assessing its pigmentation
3 and 6 months after surgery
collagen fibers arrangement under electron microscopy
Time Frame: surgery and 6 months after surgery
use the drilling device to take the skin tissue of the diameter of 3mm for histological examination, measuring the collagen fibers arrangement by Electron microscopy
surgery and 6 months after surgery
dermal matrix arrangement under electron microscopy
Time Frame: surgery and 6 months after surgery
use the drilling device to take the skin tissue of the diameter of 3mm for histological examination, measuring the dermal matrix arrangement by Electron microscopy
surgery and 6 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Xin Tang, The First Affiliated Hospital of Dalian Medical University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

May 11, 2017

Primary Completion (ANTICIPATED)

August 31, 2018

Study Completion (ANTICIPATED)

October 31, 2018

Study Registration Dates

First Submitted

April 26, 2017

First Submitted That Met QC Criteria

May 4, 2017

First Posted (ACTUAL)

May 5, 2017

Study Record Updates

Last Update Posted (ACTUAL)

May 5, 2017

Last Update Submitted That Met QC Criteria

May 4, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LCSY2017-05

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Wounds and Injuries

Clinical Trials on Skin stretching device (SSD)

Subscribe